Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026
Go back to Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026| (NASDAQ: ZYME) | Delayed: 23.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.26 | 52 Week High | $ | |||
| Open | $23.26 | 52 Week Low | $ | |||
| Day High | $23.26 | P/E | N/A | |||
| Day Low | $23.26 | EPS | $ | |||
| Volume | 182 | |||||

